Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
On June 23, 2025, the U.S. Meals and Drug Administration (FDA) granted accelerated approval to Datroway (datopotamab deruxtecan-dlnk) for the remedy of sufferers...
For sufferers with bladder most cancers present process radical cystectomy, or the surgical removing of the bladder, one potential possibility is to then...
As July concludes, new therapies provide advances throughout kidney and bladder most cancers, with breakthroughs in customized vaccines and non-surgical therapies.As July concludes,...
